Development in Alzheimer’s Disease Diagnosis in Canada: New Tests Help Patients and Caregivers Make Timely Decisions
Roche’s Cerebrospinal Fluid (CSF) assays address unmet needs in the detection of amyloid pathology by offering greater accessibility and support for Alzheimer’s disease (AD) diagnosis. Currently, AD diagnosis is largely… Read More




